Estelle Bourbon

749 total citations · 1 hit paper
14 papers, 390 citations indexed

About

Estelle Bourbon is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Estelle Bourbon has authored 14 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Estelle Bourbon's work include Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers) and Otitis Media and Relapsing Polychondritis (4 papers). Estelle Bourbon is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), CAR-T cell therapy research (4 papers) and Otitis Media and Relapsing Polychondritis (4 papers). Estelle Bourbon collaborates with scholars based in France and United States. Estelle Bourbon's co-authors include Yvan Jamilloux, Pierre Sujobert, Thomas Barba, Cécile‐Audrey Durel, Maël Heiblig, P. Sève, Jean‐Christophe Lega, Fiorenza Barraco, Gilles Salles and Pierre Sujobert and has published in prestigious journals such as Blood, British Journal of Haematology and Lara D. Veeken.

In The Last Decade

Estelle Bourbon

14 papers receiving 385 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic options in VEXAS syndrome: insights from a retrospective series

2021 161 citations Estelle Bourbon, Maël Heiblig et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estelle Bourbon France	9	277	207	86	51	47	14	390
Francis Pascal France	4	120 0.4×	147 0.7×	33 0.4×	171 3.4×	40 0.9×	7	277
Agnès Charpentier France	7	45 0.2×	145 0.7×	45 0.5×	59 1.2×	161 3.4×	13	322
Gandhi Damaj France	8	55 0.2×	78 0.4×	81 0.9×	79 1.5×	41 0.9×	16	288
Ute Apfelbeck Austria	6	61 0.2×	116 0.6×	36 0.4×	90 1.8×	132 2.8×	8	236
Vincent Jachiet France	9	97 0.4×	100 0.5×	54 0.6×	83 1.6×	71 1.5×	22	325
Xinyue Lian China	12	162 0.6×	29 0.1×	38 0.4×	39 0.8×	110 2.3×	16	427
Maria De Grandis France	11	45 0.2×	125 0.6×	32 0.4×	13 0.3×	105 2.2×	16	264
Guntram Buesche Germany	12	149 0.5×	390 1.9×	28 0.3×	19 0.4×	396 8.4×	20	513
Iris Amitay‐Laish Israel	10	52 0.2×	58 0.3×	101 1.2×	93 1.8×	81 1.7×	25	348
Hanns M. Lorenz Germany	6	84 0.3×	42 0.2×	20 0.2×	68 1.3×	16 0.3×	7	297

Countries citing papers authored by Estelle Bourbon

Since Specialization

Citations

This map shows the geographic impact of Estelle Bourbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Bourbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Bourbon more than expected).

Fields of papers citing papers by Estelle Bourbon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle Bourbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Bourbon. The network helps show where Estelle Bourbon may publish in the future.

Co-authorship network of co-authors of Estelle Bourbon

This figure shows the co-authorship network connecting the top 25 collaborators of Estelle Bourbon. A scholar is included among the top collaborators of Estelle Bourbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estelle Bourbon. Estelle Bourbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bourbon, Estelle, et al.. (2024). CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysis. Leukemia & lymphoma. 65(13). 2048–2051. 1 indexed citations

Bourbon, Estelle, Kaddour Chabane, Isabelle Mosnier, et al.. (2023). Next-CLL, a New Next-Generation Sequencing–Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia. Journal of Molecular Diagnostics. 25(5). 274–283. 2 indexed citations

Dumas, Cécile, Estelle Bourbon, Maël Heiblig, et al.. (2023). Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome. HemaSphere. 7(2). e828–e828. 14 indexed citations

Cordeil, Stéphanie, Estelle Bourbon, Emmanuelle Ferrant, et al.. (2022). Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas. Leukemia & lymphoma. 64(3). 707–711. 9 indexed citations

Mauduit, Claire, Juliette Fontaine, Estelle Bourbon, et al.. (2021). Real‐life targeted next‐generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network. British Journal of Haematology. 193(6). 1110–1122. 8 indexed citations

Heiblig, Maël, Bhavisha A. Patel, Emma M. Groarke, Estelle Bourbon, & Pierre Sujobert. (2021). Toward a pathophysiology inspired treatment of VEXAS syndrome. Seminars in Hematology. 58(4). 239–246. 45 indexed citations

Bourbon, Estelle, Hervé Ghesquières, & Emmanuel Bachy. (2021). CAR-T cells, from principle to clinical applications. Bulletin du Cancer. 108(10). S4–S17. 25 indexed citations

Barba, Thomas, Yvan Jamilloux, Cécile‐Audrey Durel, et al.. (2021). VEXAS syndrome in a woman. Lara D. Veeken. 60(11). e402–e403. 69 indexed citations

Bourbon, Estelle, Maël Heiblig, Thomas Barba, et al.. (2021). Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood. 137(26). 3682–3684. 161 indexed citations breakdown →

10.

Bourbon, Estelle, et al.. (2021). How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks. Pharmaceuticals. 14(7). 617–617. 8 indexed citations

11.

Bourbon, Estelle & Gilles Salles. (2020). Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma. Expert Opinion on Investigational Drugs. 29(10). 1079–1088. 24 indexed citations

12.

Maucort‐Boulch, Delphine, Estelle Bourbon, Lionel Karlin, et al.. (2018). Refractory diffuse large B‐cell lymphoma after first‐line immuno‐CT: Treatment options and outcomes. Hematological Oncology. 36(3). 533–542. 2 indexed citations

13.

Ranchon, Florence, Nicolas Vantard, Émilie Hénin, et al.. (2017). Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?. Hematological Oncology. 36(2). 399–406. 21 indexed citations

14.

Qu, Changju, Yadong Liu, Kranthi Kunkalla, et al.. (2011). Smoothened (SMO), a G-Protein-Coupled Receptor (GPCR) Activated by Hedgehog Ligands, Modulates the Activity Levels of PI3K/AKT and NF-Kβ in Diffuse Large B-Cell Lymphoma,. Blood. 118(21). 3483–3483. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact